Biosimilars Market Report

Osteoporosis: Global Drug Forecast and Market Analysis to 2027

Despite being a market monopolized by generics, osteoporosis is expected to undergo substantial change between 2017 and 2027.

Osteoporosis is often referred to as a “silent” disease, because the loss of bone occurs progressively and there are often no symptoms until the first fracture occurs. Despite being a market dominated by generics, osteoporosis is expected to undergo substantial change in the forecast period. Our Biosimilars market report covers topics including strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the osteoporosis therapeutics market.

  • Key Questions Answered:
  • What are the key osteoporosis treatments?
  • When will the late stage pipeline products launch, and how will it affect drug sales in the 7 major markets?
  • Which unmet needs will remain unaddressed in the forecast period?
  • What opportunities remain for pharmaceutical companies?

Changes are already being seen in the osteoporosis space, with the recent launch of Radius Health’s Tymlos (abaloparatide) in the US in 2017. Anabolic agents will continue to revolutionize the market, with the arrival of a novel sclerostin inhibitor, Evenity (romosozumab), and teriparatide biosimilars. Competition is expected to increase, driving down high price tags and potentially boosting the use of these therapies up the treatment paradigm.

Poor diagnosis rates, badly perceived drug side effects, and low compliance rates will continue to prove major hurdles for growth over the next 10 years.

 

 

Buy this report

Single user $ 10,995


Buy Now


reportstore@globaldata.com

+44 (0) 161 359 5813


Not ready to buy yet? Download our free report series guide on the Biosimilars Market

I consent to GlobalData collecting my details provided via this form.

You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our GlobalData Privacy Policy to see how we protect and manage your submitted data.